{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:26:42Z","timestamp":1790519202814,"version":"4.1.0"},"reference-count":55,"publisher":"American Society of Hematology","issue":"27","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,12,26]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Using EBMT data in &gt;2000 patients from 1994 to 2015, we analyzed the development and factors influencing outcomes of HSCT for ADs. Transplant center experience, accreditation, and national socioeconomic factors are relevant for outcomes and future health service delivery.<\/jats:p>","DOI":"10.1182\/bloodadvances.2017010041","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T01:30:39Z","timestamp":1513819839000},"page":"2742-2755","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":199,"title":["Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases"],"prefix":"10.1182","volume":"1","author":[{"given":"John A.","family":"Snowden","sequence":"first","affiliation":[{"name":"Department of Haematology, Sheffield Teaching Hospitals National Health Service Foundation Trust, Sheffield, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Badoglio","sequence":"additional","affiliation":[{"name":"European Society for Blood and Marrow Transplantation (EBMT) Paris Study Office and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Labopin","sequence":"additional","affiliation":[{"name":"Department of Haematology, Saint Antoine Hospital, INSERM Unit\u00e9 Mixte de Recherche 938, Universit\u00e9 Pierre et Marie Curie, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Giebel","sequence":"additional","affiliation":[{"name":"Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie Institute\u2013Oncology Center, Gliwice Branch, Gliwice, Poland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoin","family":"McGrath","sequence":"additional","affiliation":[{"name":"Joint Accreditation Committee of the International Society for Cellular Therapy and EBMT (JACIE) Office, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zora","family":"Marjanovic","sequence":"additional","affiliation":[{"name":"Service d'Hematologie clinique et Therapie Cellulaire, Hopital Saint-Antoine, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Burman","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Uppsala University, Uppsala, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Moore","sequence":"additional","affiliation":[{"name":"Haematology Department, St. Vincent\u2019s Health Network, Darlinghurst, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Rovira","sequence":"additional","affiliation":[{"name":"Department of Haematology, Hospital Clinic, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico M.","family":"Wulffraat","sequence":"additional","affiliation":[{"name":"Divisie Kinderen, Cluster Immunologie, Reumatologie, Hematologie en Infectiologie, Wilhelmina Kinderziekenhuis, Utrecht, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Kazmi","sequence":"additional","affiliation":[{"name":"Kings Health Partners, Department of Haematology, Guys Hospital, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Greco","sequence":"additional","affiliation":[{"name":"Hematology and Bone Marrow Transplantation Unit, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilian","family":"Snarski","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Kozak","sequence":"additional","affiliation":[{"name":"P\u0159ednosta Intern\u00ed hematologick\u00e9 kliniky, Univerzity Karlovy a Fakultn\u00ed nemocnice Kr\u00e1lovsk\u00e9 Vinohrady, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirill","family":"Kirgizov","sequence":"additional","affiliation":[{"name":"Department of Scientific Studies and Clinical Technologies, Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Alexander","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Rheumatologie und Klinische Immunologie, Charit\u00e9-Universit\u00e4tsmedizin, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bader","sequence":"additional","affiliation":[{"name":"Stammzelltransplantation und Immunologie Klinik f\u00fcr Kinder und Jugendmedizin, Frankfurt am Main, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Saccardi","sequence":"additional","affiliation":[{"name":"Haematology Department, Careggi University Hospital, Florence, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Farge","sequence":"additional","affiliation":[{"name":"Unit\u00e9 Clinique de M\u00e9decine Interne, Maladies Auto-immunes et Pathologie Vasculaire, Unit\u00e9 Fonctionnelle 04, H\u00f4pital Saint-Louis, AP-HP, INSERM Unit\u00e9 Mixte de Recherche Scientifique 1160, Paris Denis Diderot University, Paris, France; and"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies auto-immunes syst\u00e9miques Rares d\u2019Ile-de-France (site constitutif), Fili\u00e8re FAI2R, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2017,12,20]]},"reference":[{"issue":"1","key":"2019111617394612300_B1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2141.1997.3273144.x","article-title":"Haemopoietic stem cell transplantation for autoimmune diseases","volume":"99","author":"Snowden","year":"1997","journal-title":"Br J Haematol"},{"issue":"4","key":"2019111617394612300_B2","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2141.2004.05298.x","article-title":"Haemopoietic stem cell transplantation in autoimmune diseases: a European perspective","volume":"128","author":"Hough","year":"2005","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111617394612300_B3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2009.013458","article-title":"Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years\u2019 experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases","volume":"95","author":"Farge","year":"2010","journal-title":"Haematologica"},{"issue":"2","key":"2019111617394612300_B4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.retram.2016.03.003","article-title":"Haematopoietic stem cell transplantation in autoimmune diseases: from basic science to clinical practice","volume":"64","author":"Kelsey","year":"2016","journal-title":"Curr Res Transl Med"},{"issue":"7","key":"2019111617394612300_B5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.bmt.1700727","article-title":"Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT)","volume":"19","author":"Tyndall","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2019111617394612300_B6","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/bmt.2011.185","article-title":"Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation","volume":"47","author":"Snowden","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"2019111617394612300_B7","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/bmt.2017.56","article-title":"Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners","volume":"52","author":"Farge","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"2019111617394612300_B8","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/art.10495","article-title":"A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis","volume":"46","author":"Moore","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2019111617394612300_B9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1365-2141.2004.04978.x","article-title":"Haematopoetic stem cell transplantation for refractory autoimmune cytopenia","volume":"125","author":"Passweg","year":"2004","journal-title":"Br J Haematol"},{"issue":"3","key":"2019111617394612300_B10","first-page":"482","article-title":"Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR","volume":"31","author":"Snowden","year":"2004","journal-title":"J Rheumatol"},{"issue":"2","key":"2019111617394612300_B11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/ard.2006.056630","article-title":"Haematopoietic stem cell transplantation for vasculitis including Behcet\u2019s disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literature","volume":"66","author":"Daikeler","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2019111617394612300_B12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1529-8027.2009.00221.x","article-title":"Autologous peripheral blood stem cell transplantation for chronic acquired demyelinating neuropathy","volume":"14","author":"Mahdi-Rogers","year":"2009","journal-title":"J Peripher Nerv Syst"},{"issue":"3","key":"2019111617394612300_B13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/0961203312470729","article-title":"Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry [published correction appears in Lupus. 22(6):653]","volume":"22","author":"Alchi","year":"2013","journal-title":"Lupus"},{"issue":"9872","key":"2019111617394612300_B14","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(12)62114-X","article-title":"Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis","volume":"381","author":"Burt","year":"2013","journal-title":"Lancet"},{"issue":"4","key":"2019111617394612300_B15","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bbmt.2012.12.008","article-title":"Long-term outcomes of hematopoietic stem cell transplantation for severe treatment-resistant autoimmune cytopenia in children","volume":"19","author":"Rabusin","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"2019111617394612300_B16","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1136\/jnnp-2013-307207","article-title":"Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience","volume":"85","author":"Burman","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"2019111617394612300_B17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2014.17986","article-title":"Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis","volume":"313","author":"Burt","year":"2015","journal-title":"JAMA"},{"issue":"2","key":"2019111617394612300_B18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/1352458514541978","article-title":"Autologous hematopoietic stem cell transplantation in neuromyelitis optica: a registry study of the EBMT Autoimmune Diseases Working Party","volume":"21","author":"Greco","year":"2015","journal-title":"Mult Scler"},{"issue":"9","key":"2019111617394612300_B19","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/gutjnl-2015-309836","article-title":"Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn\u2019s disease","volume":"65","author":"Jauregui-Amezaga","year":"2016","journal-title":"Gut"},{"issue":"4","key":"2019111617394612300_B20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/bmt.2015.299","article-title":"Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?","volume":"51","author":"Oliveira","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2019111617394612300_B21","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/bmt.2015.294","article-title":"Immunoablation and autologous hematopoietic stem cell transplantation in the treatment of new-onset type 1 diabetes mellitus: long-term observations","volume":"51","author":"Snarski","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"10044","key":"2019111617394612300_B22","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0140-6736(16)30169-6","article-title":"Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial","volume":"388","author":"Atkins","year":"2016","journal-title":"Lancet"},{"key":"2019111617394612300_B23","first-page":"S418","article-title":"Autologous haematopoietic stem cell transplantation (AHSCT) for Crohn\u2019s disease (CD): a retrospective study of outcomes from the EBMT Autoimmune Diseases Working Party (ADWP) [abstract]","volume":"52","author":"Brierley","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"2019111617394612300_B24","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/bmt.2017.40","article-title":"Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)","volume":"52","author":"Burman","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"2019111617394612300_B25","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/ecco-jcc\/jjx054","article-title":"Autologous haematopoietic stem cell transplantation for refractory Crohn\u2019s disease: efficacy in a single-centre cohort","volume":"11","author":"L\u00f3pez-Garc\u00eda","year":"2017","journal-title":"J Crohn\u2019s Colitis"},{"issue":"4","key":"2019111617394612300_B26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/jamaneurol.2016.5867","article-title":"Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis","volume":"74","author":"Muraro","year":"2017","journal-title":"JAMA Neurol"},{"issue":"9","key":"2019111617394612300_B27","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1212\/WNL.0000000000003660","article-title":"High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS","volume":"88","author":"Nash","year":"2017","journal-title":"Neurology"},{"issue":"9790","key":"2019111617394612300_B28","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"},{"issue":"24","key":"2019111617394612300_B29","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"van Laar","year":"2014","journal-title":"JAMA"},{"issue":"10","key":"2019111617394612300_B30","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1212\/WNL.0000000000001329","article-title":"Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial","volume":"84","author":"Mancardi","year":"2015","journal-title":"Neurology"},{"issue":"23","key":"2019111617394612300_B31","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/jama.2015.16700","article-title":"Autologous hematopoetic stem cell transplantation for refractory Crohn disease: a randomized clinical trial","volume":"314","author":"Hawkey","year":"2015","journal-title":"JAMA"},{"key":"2019111617394612300_B32","author":"Sullivan"},{"issue":"6","key":"2019111617394612300_B33","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1365-2141.2012.09122.x","article-title":"Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997-2009","volume":"157","author":"Snowden","year":"2012","journal-title":"Br J Haematol"},{"key":"2019111617394612300_B34","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1182\/blood.V126.23.1985.1985","article-title":"Autologous hematopoietic stem cell transplantation (AHSCT) in severe auto-immune disease adult patients: analysis of outcomes from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGMT-TC) in light of the European Society for Blood and Marrow Transplantation (EBMT) activity [abstract]","volume":"126","author":"Guillaume-Jugnot","year":"2015","journal-title":"Blood"},{"issue":"12","key":"2019111617394612300_B35","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.ebiom.2015.11.021","article-title":"Economics and outcome after hematopoietic stem cell transplantation: a retrospective cohort study","volume":"2","author":"Gratwohl","year":"2015","journal-title":"EBioMedicine"},{"issue":"10","key":"2019111617394612300_B36","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/bmt.2017.54","article-title":"JACIE accreditation for blood and marrow transplantation: past, present and future directions of an international model for healthcare quality improvement","volume":"52","author":"Snowden","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2019111617394612300_B37","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1177\/1352458512442993","article-title":"Autologous hematopoietic stem cell transplantation for multiple sclerosis--if confused or hesitant, remember: \u2018treat with standard immune suppressive drugs and if no inflammation, no response\u2019","volume":"18","author":"Burt","year":"2012","journal-title":"Mult Scler"},{"issue":"1","key":"2019111617394612300_B38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/14712598.2017.1239706","article-title":"Autologous hematopoietic cell transplantation in multiple sclerosis","volume":"17","author":"Bell","year":"2017","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"2019111617394612300_B39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1182\/blood-2010-01-266478","article-title":"Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemia","volume":"116","author":"Giebel","year":"2010","journal-title":"Blood"},{"issue":"16","key":"2019111617394612300_B40","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.2010.491","article-title":"Hematopoietic stem cell transplantation: a global perspective","volume":"303","author":"Gratwohl","year":"2010","journal-title":"JAMA"},{"issue":"3","key":"2019111617394612300_B41","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1634\/theoncologist.2015-0314","article-title":"Association of macroeconomic factors with nonrelapse mortality after allogeneic hematopoietic cell transplantation for adults with acute lymphoblastic leukemia: an analysis from the Acute Leukemia Working Party of the EBMT","volume":"21","author":"Giebel","year":"2016","journal-title":"Oncologist"},{"issue":"3","key":"2019111617394612300_B42","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/S2352-3026(15)00028-9","article-title":"One million haemopoietic stem-cell transplants: a retrospective observational study","volume":"2","author":"Gratwohl","year":"2015","journal-title":"Lancet Haematol"},{"issue":"12","key":"2019111617394612300_B43","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1002\/art.22256","article-title":"Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens","volume":"54","author":"Burt","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2019111617394612300_B44","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/bmt.2014.248","article-title":"Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP)","volume":"50","author":"Snarski","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"2019111617394612300_B45","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.bbmt.2016.05.007","article-title":"Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT","volume":"22","author":"DeFilipp","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"2019111617394612300_B46","first-page":"665","article-title":"A preliminary online study on menstruation recovery in women after autologous hematopoietic stem cell transplant for autoimmune diseases","volume":"14","author":"Maciejewska","year":"2016","journal-title":"Exp Clin Transplant"},{"issue":"5","key":"2019111617394612300_B47","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20041679","article-title":"Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients","volume":"201","author":"Muraro","year":"2005","journal-title":"J Exp Med"},{"issue":"3","key":"2019111617394612300_B48","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1172\/JCI71691","article-title":"T cell repertoire following autologous stem cell transplantation for multiple sclerosis","volume":"124","author":"Muraro","year":"2014","journal-title":"J Clin Invest"},{"issue":"1","key":"2019111617394612300_B49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1182\/blood-2015-06-649145","article-title":"Autologous stem cell transplantation aids autoimmune patients by functional renewal and TCR diversification of regulatory T cells","volume":"127","author":"Delemarre","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2019111617394612300_B50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13045-016-0388-5","article-title":"Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients","volume":"10","author":"Farge","year":"2017","journal-title":"J Hematol Oncol"},{"issue":"2","key":"2019111617394612300_B51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/bmt.2014.251","article-title":"SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking","volume":"50","author":"Alexander","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2019111617394612300_B52","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1182\/blood-2015-11-678607","article-title":"Rebooting autoimmunity with autologous HSCT","volume":"127","author":"Snowden","year":"2016","journal-title":"Blood"},{"issue":"6","key":"2019111617394612300_B53","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/bmt.2009.305","article-title":"Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis","volume":"45","author":"Tappenden","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"2019111617394612300_B54","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00592-015-0724-1","article-title":"An economic analysis of autologous hematopoietic stem cell transplantation (AHSCT) in the treatment of new onset type 1 diabetes","volume":"52","author":"Snarski","year":"2015","journal-title":"Acta Diabetol"},{"key":"2019111617394612300_B55","first-page":"S41","article-title":"EBMT Autoimmune Diseases Working Party. Evaluating the cost-effectiveness of autologous haematopoietic stem cell transplantation (aHSCT) versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison (MAIC) [abstract]","volume":"52","author":"Tappenden","year":"2017","journal-title":"Bone Marrow Transplant"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/27\/2742\/879369\/advances010041.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/1\/27\/2742\/879369\/advances010041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T22:40:06Z","timestamp":1573944006000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/1\/27\/2742\/15827\/Evolution-trends-outcomes-and-economics-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,20]]},"references-count":55,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2017,12,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2017010041","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,20]]}}}